MX9709090A - Quimiocina beta-11 humana y quimiocina alfa-1 humana. - Google Patents

Quimiocina beta-11 humana y quimiocina alfa-1 humana.

Info

Publication number
MX9709090A
MX9709090A MX9709090A MX9709090A MX9709090A MX 9709090 A MX9709090 A MX 9709090A MX 9709090 A MX9709090 A MX 9709090A MX 9709090 A MX9709090 A MX 9709090A MX 9709090 A MX9709090 A MX 9709090A
Authority
MX
Mexico
Prior art keywords
disclosed
polypeptides
chemokine
chemokine polypeptides
human chemokine
Prior art date
Application number
MX9709090A
Other languages
English (en)
Other versions
MXPA97009090A (es
Inventor
Haodong Li
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Priority claimed from PCT/US1996/009572 external-priority patent/WO1996039522A1/en
Publication of MXPA97009090A publication Critical patent/MXPA97009090A/es
Publication of MX9709090A publication Critical patent/MX9709090A/es

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen los polipéptidos de quimiocina humana y el ADN (ARN) que codifica para tales polipéptidos de quimiocina, y un procedimiento para la produccion de tales polipéptidos mediante técnicas recombinantes. También se describen los métodos para la utilizacion de tales polipéptidos de quimiocina para el tratamiento de leucemia, tumores, infecciones cronicas, enfermedades autoinmunes, desordenes fibroticos, sanado de heridas y psoriasis. También se describen los antagonistas contra tales polipéptidos de quimiocina y su uso como un agente terapéutico para tratar artritis reumatoide, enfermedades autoinmunes e infecciones inflamatorias cronicas y agudas, reacciones alérgicas, fiebre independiente de prostaglandina y falla de la médula osea. También se describen los ensayos de diagnostico para detectar las enfermedades relaciones a las mutaciones en las secuencias de ácido nucleico y las concentraciones alteradas de los polipéptidos. Se describen también los ensayos de diagnostico para detectar mutaciones en los polinucleotidos que codifican para los polipéptidos de quimiocina, y para detectar los niveles del polipéptido en un huésped.
MX9709090A 1995-06-05 1996-06-05 Quimiocina beta-11 humana y quimiocina alfa-1 humana. MX9709090A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US464401 1983-02-07
US46440195A 1995-06-05 1995-06-05
US460987 1995-06-05
PCT/US1996/009572 WO1996039522A1 (en) 1995-06-05 1996-06-05 Human chemokine beta-11 and human chemokine alpha-1

Publications (2)

Publication Number Publication Date
MXPA97009090A MXPA97009090A (es) 1998-01-01
MX9709090A true MX9709090A (es) 1998-01-31

Family

ID=39165773

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9709090A MX9709090A (es) 1995-06-05 1996-06-05 Quimiocina beta-11 humana y quimiocina alfa-1 humana.

Country Status (1)

Country Link
MX (1) MX9709090A (es)

Similar Documents

Publication Publication Date Title
MX9708537A (es) Quimiocina beta-8 quimiocina beta-1 y proteina-4 inflamatoria de los macrofagos, humanas.
DE69533627D1 (en) Humanes chemokin beta-13
ATE262345T1 (de) Menschliche chemokin-polypeptide
WO1997035010A8 (en) Chemokine alpha 2
AU2814195A (en) Human chemokine beta-9
EP0814158A3 (en) Human C3a receptor variant; uses in diagnostics and therapeutics
AU1724795A (en) Human tissue inhibitor of metalloproteinase-4
EP0823478A3 (en) Human cartilege GP 39-like gene
EP0792370A4 (en) INTERLEUKIN-1 CONVERSION ENZYME-TYPE APOPTOSIS PROTEASE-3 AND 4 -g (b)
ES2068791T1 (es) Metodos y acido desoxirribonucleico para la preparacion de proteina de factor de tejido.
EP0837138A3 (en) Novel topoisomerase III
EP0826774A3 (en) Staphylococcal Fab I enoyl-ACP reductase
EP0812913A3 (en) HR-1 receptor, a receptor of the cytokine receptors family
EP0837137A3 (en) Novel topoisomerase III
WO2003029423A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
MX9709090A (es) Quimiocina beta-11 humana y quimiocina alfa-1 humana.
EP0808899A3 (en) Human marco scavenger receptor (HMarcoSR)
EP0845535A3 (en) Leader peptidase (lep) from Streptococcus
WO2003031571A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
EP0835938A3 (en) Topoisomerase I
EP0837136A3 (en) Novel topoisomerase I
EP0841399A3 (en) Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor
WO2003085124A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP0846766A3 (en) IgA Fc binding protein from Streptococcus pneumoniae
WO2003050245A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use